Replication-competent vesicular stomatitis virus vaccine vector protects against SARS-CoV-2-mediated pathogenesis
James Brett Case, Paul Rothlauf, Rita E. Chen, Natasha Kafai, Julie M. Fox, Swathi Shrihari, Broc T. McCune, Ian B. Harvey, Brittany Smith, Shamus Keeler, Louis-Marie Bloyet, Emma S Winkler, Michael J. Holtzman, Daved H. Fremont, Sean P. J. Whelan, Michael S. Diamond
This study develops a replication-competent VSV-based vaccine against SARS-CoV-2 that elicits neutralizing antibodies and protects mice from viral infection and lung inflammation.
Cell Host & Microbe · Sep 1, 2020Peer-reviewedImmunology